What is the price target for LMRI stock?
14 analysts have analysed LMRI and the average price target is 20.4 USD. This implies a price increase of 116.68% is expected in the next year compared to the current price of 9.415.
LUMEXA IMAGING HOLDINGS INC (LMRI) Forecast, Price Target & Analyst Ratings
NASDAQ:LMRI • US5502491062
Current stock price
9.415 USD
+0.04 (+0.48%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LUMEXA IMAGING HOLDINGS INC (LMRI).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q1 / 2026
- EPS Estimate
- $0.12
- Revenue Estimate
- 256.02M
Price Target Details & History
Consensus Price Target and Range
Mean target
$20.40
Upside
+ 116.68%
From current price of $9.42 to mean target of $20.40, Based on 14 analyst forecasts
Low
$13.13
Median
$22.44
High
$24.15
Price Target Revisions
1 Month
-11.50%
3 Months
-11.50%
Price Target Summary
14 Wall Street analysts provided a forecast for the next 12 months for LMRI. The average price target is 20.4 USD. This implies a price increase of 116.68% is expected in the next year compared to the current price of 9.415.
The average price target has been revised downward by 11.5% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
87.14%
LMRI was analyzed by 14 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about LMRI.
In the previous month the buy percentage consensus was at a similar level.
LMRI was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-14 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-09 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2026-01-05 | Leerink Partners | Initiate | Outperform |
| 2026-01-05 | William Blair | Initiate | Outperform |
| 2026-01-05 | Deutsche Bank | Initiate | Buy |
| 2026-01-05 | Barclays | Initiate | Overweight |
| 2026-01-05 | Wells Fargo | Initiate | Overweight |
| 2026-01-05 | Raymond James | Initiate | Outperform |
| 2026-01-05 | Jefferies | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q1 / 2026
- EPS Estimate
- $0.12
- Revenue Estimate
- 256.02M
- Revenue Q2Q
- N/A
- EPS Q2Q
- N/A
- Number of Analysts
- 10
Next Earnings Revisions
Revenue (1 Month)
-1.44%
Revenue (3 Months)
N/A
EPS (1 Month)
-27.41%
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 935.925M | 948.869M 1.38% | 1.023B 7.82% | 1.088B 6.35% | 1.149B 5.61% | 1.214B 5.66% | 1.28B 5.44% | 1.351B 5.55% | |
| EBITDA YoY % growth | 43.802M | 25.902M -40.87% | 67.112M 159.10% | 242.05M 260.67% | 261.62M 8.09% | 281.52M 7.61% | N/A | N/A | |
| EBIT YoY % growth | -12.828M | -16.262M -26.77% | 26.733M 264.39% | 155.6M 482.05% | 186.24M 19.69% | N/A | N/A | N/A | |
| Operating Margin | -1.37% | -1.71% | 2.61% | 14.30% | 16.21% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | 0.72 1,427.58% | 0.99 37.01% | 1.07 8.25% | 1.32 22.86% | 1.48 12.40% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.12 | 0.18 | 0.20 | 0.23 216.57% | 0.21 68.82% | 0.24 31.94% | 0.26 26.81% | 0.29 24.69% | 0.22 7.32% | 0.24 1.05% | 0.26 | 0.28 -5.26% |
| Revenue Q2Q % growth | 256.02M | 269.45M | 277.26M -63.29% | 285.31M 6.56% | 269.28M 5.18% | 284.35M 5.53% | 291.28M 5.06% | 302.14M 5.90% | 285.44M 6.00% | 298.74M 5.06% | 303.65M 4.25% | 312.25M 3.35% |
| EBITDA Q2Q % growth | 52.14M | 59.793M | 62.577M 0.63% | 67.251M 104.35% | 58.7M 12.58% | 64.328M 7.58% | 66.908M 6.92% | 71.483M 6.29% | 64.332M 9.59% | 69.269M 7.68% | 70.704M 5.67% | 74.57M 4.32% |
| EBIT Q2Q % growth | 30.025M | 36.165M | 39.241M 14.73% | 44.254M 692.42% | 42.472M 41.46% | 46.273M 27.95% | 48.249M 22.96% | 52.944M 19.64% | 40.553M -4.52% | 44.379M -4.09% | 45.513M -5.67% | 48.619M -8.17% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
178.88%
EPS Next 5 Year
96.36%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
5.39%
Revenue Next 5 Year
5.43%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
27.19%
EBIT Next 5 Year
N/A
LUMEXA IMAGING HOLDINGS INC / LMRI Forecast FAQ
What are the consensus estimates for LMRI stock next earnings?
The consensus EPS estimate for the next earnings of LUMEXA IMAGING HOLDINGS INC (LMRI) is 0.12 USD and the consensus revenue estimate is 256.02M USD.
Can you provide the expected long term growth rate for LUMEXA IMAGING HOLDINGS INC stock?
The expected long term growth rate for LUMEXA IMAGING HOLDINGS INC (LMRI) is 5.39%.